Lecanemab in early Alzheimer's disease

Authors

Christopher H van Dyck, Yale University
Randall J Bateman, Washington University School of Medicine in St. Louis
et al.

Journal

New England Journal of Medicine

Publication Date

1-5-2023

Volume

388

Issue

1

First Page

9

Last Page

21

Document Type

Open Access Publication

DOI

10.1056/NEJMoa2212948

Rights and Permissions

van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T. Lecanemab in Early Alzheimer's Disease. N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Copyright © 2023 Massachusetts Medical Society. Reprinted with permission.

Recommended Citation

van Dyck, Christopher H; Bateman, Randall J; and et al., "Lecanemab in early Alzheimer's disease." New England Journal of Medicine. 388, 1. 9 - 21. (2023).
https://digitalcommons.wustl.edu/oa_4/2191

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.